FINAL PROGRAM - Society of Behavioral Medicine

More documents

Recommendations

Info

31 st Annual Meeting & Scientific SessionsBehavioral Medicine: Building for the FutureScientific Sessions – Wednesday, April 7, 201012:00 pm – 2:45 pm Early Afternoon SeminarsSeminar 4: Understanding Patient Preferences for Prevention and TreatmentSara J. Knight, PhD, San Francisco VA Medical Center and the University of California San Francisco,San Francisco, CA.Pre-registration and ticket required. See registration desk for fee.Willow A, 2 nd FloorSummary: Understanding patient preferences for prevention and treatment is critical in the predictionof patient involvement in health behavior and medical care. While preferences can be evaluated withratings, rankings, utilities elicitation, and conjoint analysis, few of these methods have been developedto meet rigorous psychometric standards. In this seminar, we will discuss theories of patient preferencesand methods for preference measurement, focusing especially on building instruments that have strongpsychometric qualities. We will provide an overview of current conceptual models from behavioral scienceand health economics and we will demonstrate measurement methods including standard gamble,time trade-off, conjoint analysis, best worst scaling, and importance ratings. Using hands-on exercises,we will demonstrate how qualitative data can be used to generate the health state descriptions andchoice alternative attributes that form the foundation of a preference measure. Finally, we will present aframework for evaluating the validity and reliability of preference measures. Examples from research ongeriatric medicine, cancer treatment, and palliative care will provide concrete illustrations. Using a smallgroup format, participants will have an opportunity to practice preference assessment and to discuss thebest strategies for measuring patient preferences in their own research and clinical applications.Seminar 5: Evaluating Meta Analyses: A Critical Consumers’ GuideJames C. Coyne, PhD, University of Pennsylvania, Philadelphia, PA.Pre-registration and ticket required. See registration desk for fee.Issaquah AB, 3 rd FloorSummary: This workshop will present basic principles for evaluating the credibility of the conclusionsof a meta-analysis. Increasingly, researchers and evidence-oriented clinicians and policy makers areurged to rely on the results of meta-analyses for decision-making. Yet, recent criticisms of meta-analysesthat have appeared in Annals of Behavioral Medicine, Health Psychology, and even JAMA demonstratethat meta-analysis is hardly a straightforward, objective procedure, but one for which there is considerableroom for subjective and arbitrary judgment. Further, a meta-analysis depends on the quality of thestudies on which it draws and how their limitations are accommodated. Overall, it is quite possible fortwo meta-analyses to differ greatly in their results and recommendations because of differences in searchstrategies, selection criteria, and choices made as to how to deal with the methodological limitations ofthe available trials. Thus, meta analyses can fall short, either because their failure to observe basic principlesfor how they should be conducted and reported, or because of how decisions that were made as tohow to deal with the available trials. The latter decisions require a familiarity with the interventions beingstudied and the clinical context in which they will be implemented, or, as the presenters have termedit, a clinical connoisseurship. This workshop is most appropriate for consumers of meta-analyses havingto make clinical or policy decisions, those who might be contemplating doing a critical re-analysisof a published meta-analysis, and those who are conducting a meta-analysis of their own in which theyavoid likely problems and pitfalls. Discussion will center not only on how to do a meta-analysis, but alsoon how to publish one with adequate transparency. It will present a guide to some necessary summarystatistics and their interpretation. Participants will be able to appreciate when results of a meta-analysis“ain’t necessarily so”. Both primary presenters have published primary meta-analyses as well as critiquesof published meta-analyses.20
31 st Annual Meeting & Scientific SessionsBehavioral Medicine: Building for the FutureScientific Sessions – Wednesday, April 7, 201012:00 pm – 2:45 pm Early Afternoon SeminarsSeminar 6: Clinical Seminar in Behavioral Activation Treatment for Depression With a Co-MorbidHealth ConditionSherry Pagoto, PhD, University of Massachusetts Medical School, Worcester, MA.Pre-registration and ticket required. See registration desk for fee.Wallingford, 3 rd FloorSummary: Depression is co-morbid with many health conditions, including type 2 diabetes, HIV/AIDS,CVD, obesity, smoking, and substance abuse. Depression is associated with treatment nonadherence,poor self-care, and unhealthy lifestyle behaviors. Brief Behavioral Activation Treatment for Depression(BATD) is an evidence-based therapy for depression that is uniquely suited for use in medical settings,given its straightforward, time efficient nature, and ease of application to co-morbid health conditions.BATD is based on reinforcement theory and specifically targets contextual factors that affect behavior usingprinciples of the matching law. Matching law suggests that depression persists because reinforcementfor healthy behavior is low, and/or depressed behavior produces a relatively high rate of reinforcement.BATD is designed to increase exposure to positive consequences of healthy behavior, thereby increasingthe likelihood of such behavior and reducing the likelihood of future depressed behavior. In addition todepression, BATD has been applied successfully to health conditions such as obesity, type 2 diabetes,HIV/AIDS, anxiety disorders, cancer, smoking, and substance abuse. The purpose of this clinical seminaris for participants to learn how to administer BATD in the context of a co-morbid health condition for thepurpose of reducing depressive symptomatology as well as increasing healthy behaviors (e.g., healthydiet, physical activity, and medical adherence) and decreasing unhealthy behaviors (e.g., smoking, overeating,alcohol use). In this seminar, we will teach the basic principles of BATD, briefly review the efficacyliterature, provide session-by-session instructions, and outline strategies for adapting BATD for applicationto a wide variety of medical conditions with practical recommendations on addressing barriers,including treatment resistance and integration into other treatments. Participants will receive a treatmentmanual and reference list. All skill levels are welcome.3:15 pm – 6:00 pm Late Afternoon SeminarsSeminar 7: Translation Research: Design and Methodology ConsiderationsChristine Hunter, PhD, National Institute of Diabetes & Digestive & Kidney Diseases, Arlington, VA.Pre-registration and ticket required. See registration desk for fee.Aspen, 2 nd FloorSummary: Although basic science and efficacy research play a critical role in scientific advancement,improved public health is not always realized because of challenges related to translation from benchto beside and bedside to community. Analogous to the search for biological mechanisms as targets fordrugs, basic behavioral and social science research requires translation into novel clinical approaches.Once efficacy of a new approach is established, later phase translation research is then needed to addressgeneralizability, adoption, implementation, cost, and sustainability. Promoting high quality translationresearch is an important step towards bridging the gap between science and practice. For many investigatorstrained in traditional randomized controlled trial design and methodology, moving into translationresearch requires a new skill set that includes an appreciation of the strengths and limitations of varioustypes of translation research. Early phase translation often requires transdiciplinary teams to conductformative and pilot research. Moving from established efficacy research into effectiveness trials requiresresearch designs that balance internal and external validity and researchers that understand the uniqueissues related to selecting a sample, considering comparison condition options, and approach to causalinference. This seminar is designed to provide a beginner to intermediate level overview of factors toconsider when approaching translation research. The specific topics covered in the seminar include anoverview of the continuum of translational research and discussion of research opportunities includingdesigns and methodologies that are useful for the different phases of translation. The seminar format willinclude instruction and active discussion between speakers and attendees.21
Page 3 and 4: 31 st Annual Meeting & Scientific S
Page 21: 31 st Annual Meeting & Scientific S
Page 73 and 74:
31 st Annual Meeting & Scientific S
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
2010 Membership ApplicationPersonal
Page 97 and 98:
2010 Membership ApplicationCommitte
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111:
Page 114 and 115:
Page 116 and 117:
show all

FINAL PROGRAM - Society of Behavioral Medicine

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?